Literature DB >> 16244257

Liver metastases in rats: chemoembolization combined with interstitial laser ablation for treatment.

Adel Maataoui1, Jun Qian, Martin G Mack, Mohammad F Khan, Elsie Oppermann, Mehry Roozru, Sabine Schmidt, Wolf O Bechstein, Thomas J Vogl.   

Abstract

PURPOSE: To assess the effect of transcatheter arterial chemoembolization (TACE) combined with laser-induced thermotherapy (LITT) for treatment of liver metastases in an animal model.
MATERIALS AND METHODS: All experiments were approved by the German government and the institutional animal research review board. After subcapsular liver implantation of colorectal cancer cells in 30 WAG rats (on day 0), the animals were randomly assigned to three interventional treatment groups. In the 10 rats in group A, TACE was performed: Fourteen days after cancer cell implantation and within 20 minutes after laparotomy and retrograde placement of a microcatheter into the gastroduodenal artery, these rats were injected with mitomycin (0.1 mg), iodized oil (0.1 mL), and degradable starch microspheres (5.0 mg). In the 10 rats in group B, LITT was performed: Also on day 14, the tumors in these animals were exposed to Nd:YAG laser light of 1064 nm at 2 W for 5 minutes. In the 10 rats in group C, combined treatment was administered: TACE was performed on day 14, and LITT was performed on day 21. Tumor volumes were measured before (on day 13) and after (on day 28) treatment with magnetic resonance (MR) imaging, and the mean tumor growth ratio (day 13 tumor volume divided by day 28 tumor volume) was calculated.
RESULTS: The mean tumor volumes measured before and after the treatments were, respectively, 0.11 and 0.60 cm(3) in group A, 0.11 and 0.68 cm(3) in group B, and 0.11 and 0.35 cm(3) in group C. The mean tumor growth ratio was 5.42 in group A, 6.14 in group B, and 3.15 in group C. According to Bonferroni test results, compared with the rats in groups A and B (controls), the group C rats had significantly inhibited tumor growth (P < .01 for both comparisons).
CONCLUSION: Use of combined TACE-LITT treatment, compared with the use of TACE or LITT alone, significantly inhibits tumor growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16244257     DOI: 10.1148/radiol.2372041494

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  The influence of Nd:YAG laser irradiation on Fluoroptic® temperature measurement: an experimental evaluation.

Authors:  Frank Hübner; Babak Bazrafshan; Jörg Roland; Antje Kickhefel; Thomas Josef Vogl
Journal:  Lasers Med Sci       Date:  2012-04-04       Impact factor: 3.161

2.  Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.

Authors:  Guang-Zhi Wang; Wei Zhang; Zhu-Ting Fang; Wen Zhang; Min-Jie Yang; Guo-Wei Yang; Shuo Li; Lian Zhu; Li-Li Wang; Wei-Sheng Zhang; Rong Liu; Sheng Qian; Jian-Hua Wang; Xu-Dong Qu
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-23       Impact factor: 4.553

3.  Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.

Authors:  Thomas Josef Vogl; Jun Qian; Andreas Tran; Elsie Oppermann; Nagy N Naguib; Huedayi Korkusuz; Nour Eldin A Nour Eldin; Wolf Otto Bechstein
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

4.  Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.

Authors:  Marco A Alcala; Shu Ying Kwan; Chad M Shade; Megan Lang; Hyounsoo Uh; Manyan Wang; Stephen G Weber; David L Bartlett; Stéphane Petoud; Yong J Lee
Journal:  Nanomedicine       Date:  2010-10-12       Impact factor: 5.307

5.  Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced thermotherapy in patients with liver metastases of colorectal carcinoma.

Authors:  T J Vogl; A Jost; N A Nour-Eldin; M G Mack; S Zangos; N N N Naguib
Journal:  Br J Cancer       Date:  2012-03-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.